The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Association Between the UGT1A1*28 Allele, Bilirubin Levels, and Coronary Heart Disease in the Framingham Heart Study
Open accessAbstract
Background— Bilirubin is an antioxidant that suppresses lipid oxidation and retards atherosclerosis formation. An inverse association between serum bilirubin and coronary heart disease has been reported. Linkage studies have identified a major locus at the chromosome 2q telomere that affects bilirubin concentrations. A candidate gene in the linkage region encodes hepatic bilirubin uridine diphosphate–glucuronosyltransferase (UGT1A1). The insertion of a TA in the TATAA box of the gene, an allele designated UGT1A1*28, decreases gene transcription. Individuals homozygous for UGT1A1*28 (genotype 7/7) have increased serum bilirubin levels compared with carriers of the 6 allele. To date, no significant association between UGT1A1*28 and cardiovascular disease (CVD) events has been reported. We performed an association study in the Framingham Heart Study population to investigate whether UGT1A1*28 is associated with the risk of CVD events. Methods and Results— The study population included 1780 unrelated individuals from the Offspring cohort (49% males, mean age 36 years at entry) who had been followed up for 24 years. Individuals with genotype 7/7 had significantly higher bilirubin levels (mean±SD 1.14±0.44 mg/dL) than those with genotypes 6/6 and 6/7 (mean±SD 0.69±0.27 mg/dL, P <0.01). Using the Cox proportional hazards model, we found significant associations between the UGT1A1*28 allele and decreased risk of CVD. Individuals with genotype 7/7 (population frequency of 11%) had approximately one third the risk for CVD and coronary heart disease as carriers of the 6 allele, which resulted in a hazard ratio (95% confidence interval) of 0.36 (0.18 to 0.74) and 0.30 (0.12 to 0.74), respectively. Conclusions— Homozygote UGT1A1*28 allele carriers with higher serum bilirubin concentrations exhibit a strong association with lower risk of CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645
The Framingham Study: The Epidemiology of Atherosclerotic Disease
Dawber, T. R. (1980) · Harvard University Press eBooks · doi:10.4159/harvard.9780674492097 · Cited by 1,454
Bosma, P. J., Chowdhury, J. R., Bakker, C., Gantla, S., de Boer, A., Oostra, B. A., Lindhout, D., Tytgat, G. N. J., Jansen, P. L. M., Elferink, R. P. J. O., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331802 · Cited by 1,447
Beutler, E., Gelbart, T., & Demina, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8170 · Cited by 853
Antioxidant activity of albumin-bound bilirubin.
Stocker, R., Glazer, A. N., & Ames, B. N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5918 · Cited by 766
Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome
Monaghan, G., Ryan, M., Hume, R., Burchell, B., & Seddon, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91273-8 · Cited by 585
Neuzil, J., & Stocker, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89449-8 · Cited by 508
Association of low serum concentration of bilirubin with increased risk of coronary artery disease
Schwertner, H. A., Jackson, W. G., & Tolan, G. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.1.18 · Cited by 474
Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels
Vı́tek, L., Jirsa, M., Brodanová, M., Kaláb, M., Mareček, Z., Danzig, V., Novotný, L., & Kotal, P. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00601-3 · Cited by 429
Premature mortality from coronary heart disease. The Framingham study
Gordon, T. (1971) · JAMA · doi:10.1001/jama.215.10.1617 · Cited by 387
Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery Disease
Hopkins, P. N., Wu, L. L., Hunt, S. C., James, B. C., Vincent, G. M., & Williams, R. R. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.2.250 · Cited by 367
Self-citationTotal serum bilirubin and risk of cardiovascular disease in the Framingham offspring study
Djoussé, L., Levy, D., Cupples, L. A., Evans, J. C., D’Agostino, R. B., & Ellison, R. C. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01494-1 · Cited by 263
Self-citationBilirubin: A Natural Inhibitor of Vascular Smooth Muscle Cell Proliferation
Öllinger, R., Bilban, M., Erat, A., Froio, A., McDaid, J., Tyagi, S., Csizmadia, E., Graça-Souza, A. V., Liloia, A., Soares, M. P., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.528802 · Cited by 241
Serum bilirubin and risk of ischemic heart disease in middle-aged British men
Breimer, L. H., Wannamethee, G., Ebrahim, S., & Shaper, A. G. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.10.1504 · Cited by 229
Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins
Wu, T.-W., Fung, K. P., Wu, J., Yang, C.-C., & Weisel, R. D. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02395-x · Cited by 215
Bosma, P. J., Chowdhury, N. R., Goldhoorn, B. G., Hofker, M. H., Elferink, R. P. J. O., Jansen, P. L. M., & Chowdhury, J. R. (1992) · Hepatology · doi:10.1002/hep.1840150531 · Cited by 198
Seppen, J., Bosma, P. J., Goldhoorn, B. G., Bakker, C. T., Chowdhury, J. R., Chowdhury, N. R., Jansen, P. L., & Oude Elferink, R. P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117604 · Cited by 171
Raijmakers, M. T. M., Jansen, P. L. M., Steegers, E. A. P., & Peters, W. H. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80268-8 · Cited by 170
Tanaka, H., Sukhova, G. K., Schwartz, D., & Libby, P. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.1.12 · Cited by 131
Schwertner, H. A. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00232-3 · Cited by 118
Hunt, S. C., Kronenberg, F., Eckfeldt, J. H., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00420-2 · Cited by 86
Self-citationAdegoke, O. J., Shu, X. O., Gao, Y., Cai, Q., Breyer, J. P., Smith, J. R., & Zheng, W. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000025419.26423.b8 · Cited by 77
Genetic heterogeneitiy of Crigler-Najjar syndrome type I: A study of 14 cases
Labrune, P., Myara, A., Hadchouel, M., et al. (1994) · Human Genetics · doi:10.1007/bf00206965 · Cited by 72
Schwertner, H. A., & FISCHER, J. R. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00387-1 · Cited by 63
A genome scan for loci influencing anti-atherogenic serum bilirubin levels
Kronenberg, F., Coon, H. H., Gutin, A., et al. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200842 · Cited by 42
Self-citation
Cited by
Allen, L. A., Felker, G. M., Pocock, S., McMurray, J. J. V., Pfeffer, M. A., Swedberg, K., Wang, D., Yusuf, S., Michelson, E. L., Granger, C. B., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn031 · Cited by 425
Bilirubin in clinical practice: a review
Fevery, J. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01716.x · Cited by 374
The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms
Meech, R., Hu, D. G., McKinnon, R. A., Mubarokah, S. N., Haines, A. Z., Nair, P. C., Rowland, A., & Mackenzie, P. I. (2019) · Physiological Reviews · doi:10.1152/physrev.00058.2017 · Cited by 368
Bilirubin in the Liver–Gut Signaling Axis
Hamoud, A.-R., Weaver, L., Stec, D. E., & Hinds, T. D. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.01.002 · Cited by 254
Zheng, J., Inoguchi, T., Sasaki, S., Maeda, Y., McCarty, M. F., Fujii, M., Ikeda, N., Kobayashi, K., Sonoda, N., & Takayanagi, R. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00648.2011 · Cited by 201
Metadata
- Authors
- Lin, J.-P., O’Donnell, C. J., Schwaiger, J. P., Cupples, L. A., Lingenhel, A., Hunt, S. C., Yang, S., & Kronenberg, F.
- Venue
- Circulation
- Published
- 2006-10-03
- Volume
- 114
- Issue
- 14
- Pages
- 1476-1481
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1979560937
- Cited by
- 314
- References
- 25
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.